Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-30 7:01 pm Purchase | 2025-05-22 | 13G | Ventyx Biosciences, Inc. VTYX | Affinity Healthcare Fund, LP | 4,057,105 5.700% | 4,057,105 (New Position) | Filing History |
| 2025-05-15 5:29 pm Sale | 2025-03-31 | 13G | Ventyx Biosciences, Inc. VTYX | Citadel Advisors LLC | 1,409,601 2.000% | -2,869,952 (-67.06%) | Filing History |
| 2025-05-15 1:10 pm Sale | 2025-03-31 | 13G | Ventyx Biosciences, Inc. VTYX | BANK OF AMERICA CORP BAC | 1,016,649 1.400% | -3,599,887 (-77.98%) | Filing History |
| 2025-04-08 3:14 pm Sale | 2025-03-31 | 13G | Ventyx Biosciences, Inc. VTYX | Sio Capital Management LLC | 2,582,655 3.630% | -1,464,142 (-36.18%) | Filing History |
| 2025-04-01 9:40 pm Purchase | 2025-03-28 | 13D | Ventyx Biosciences, Inc. VTYX | NSV Partners III, L.P. | 4,089,975 5.700% | 4,089,975 (New Position) | Filing History |
| 2025-03-12 4:05 pm Sale | 2025-03-10 | 13D | Ventyx Biosciences, Inc. VTYX | NSV Investments I, L.P. | 5,425,425 7.600% | -1,677,544 (-23.62%) | Filing History |
| 2025-02-14 6:09 pm Purchase | 2024-12-31 | 13G | Ventyx Biosciences, Inc. VTYX | BANK OF AMERICA CORP BAC | 4,616,536 6.500% | 4,616,536 (New Position) | Filing History |
| 2025-02-13 08:59 am Sale | 2024-12-31 | 13G | Ventyx Biosciences, Inc. VTYX | James E. Flynn | 534,737 0.760% | -6,180,764 (-92.04%) | Filing History |
| 2025-02-10 12:59 pm Purchase | 2024-12-31 | 13G | Ventyx Biosciences, Inc. VTYX | Sio Capital Management LLC | 4,046,797 5.720% | 4,046,797 (New Position) | Filing History |
| 2025-01-29 6:58 pm Purchase | 2025-01-22 | 13G | Ventyx Biosciences, Inc. VTYX | Point72 Asset Management, L.P. | 4,400,325 6.200% | 4,353,640 (+9325.56%) | Filing History |
| 2024-11-14 7:54 pm Sale | 2024-09-30 | 13G | Ventyx Biosciences, Inc. VTYX | Point72 Asset Management, L.P. | 46,685 0.100% | -2,970,408 (-98.45%) | Filing History |
| 2024-11-14 3:06 pm Sale | 2024-09-30 | 13G | Ventyx Biosciences, Inc. VTYX | Cormorant Asset Management LP | 0 0.000% | -3,670,000 (Position Closed) | Filing History |
| 2024-11-14 08:57 am Purchase | 2024-09-30 | 13G | Ventyx Biosciences, Inc. VTYX | James E. Flynn | 6,715,501 9.500% | 3,173,501 (+89.60%) | Filing History |
| 2024-11-12 5:45 pm Unchanged | 2024-09-30 | 13G | Ventyx Biosciences, Inc. VTYX | The Vanguard Group | 3,467,721 4.900% | 0 (Unchanged) | Filing History |
| 2024-11-04 1:46 pm Sale | 2024-09-30 | 13G | Ventyx Biosciences, Inc. VTYX | The Vanguard Group | 3,467,721 4.900% | -274,204 (-7.33%) | Filing History |
| 2024-06-26 5:16 pm Sale | 2024-06-24 | 13D | Ventyx Biosciences, Inc. VTYX | NSV Investments I, L.P. | 7,102,969 10.100% | -1,336,666 (-15.84%) | Filing History |
| 2024-04-04 12:52 pm Purchase | 2024-03-15 | 13G | Ventyx Biosciences, Inc. VTYX | James E. Flynn | 3,542,000 5.030% | 3,542,000 (New Position) | Filing History |
| 2024-03-21 4:02 pm Purchase | 2024-03-11 | 13G | Ventyx Biosciences, Inc. VTYX | Cormorant Asset Management LP | 3,670,000 5.210% | 3,670,000 (New Position) | Filing History |
| 2024-03-13 6:04 pm Unchanged | 2024-03-11 | 13D | Ventyx Biosciences, Inc. VTYX | NSV Investments I, L.P. | 8,439,635 12.000% | 0 (Unchanged) | Filing History |
| 2024-03-08 4:05 pm Sale | 2024-03-06 | 13D | Ventyx Biosciences, Inc. VTYX | NSV Investments I, L.P. | 8,439,635 14.200% | -117,231 (-1.37%) | Filing History |